Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Xiu-juan Qu"'
Autor:
Feng‐Hua Wang, Xiao‐Tian Zhang, Lei Tang, Qi Wu, Mu‐Yan Cai, Yuan‐Fang Li, Xiu‐Juan Qu, Hong Qiu, Yu‐Jing Zhang, Jie‐Er Ying, Jun Zhang, Ling‐Yu Sun, Rong‐Bo Lin, Chang Wang, Hao Liu, Miao‐Zhen Qiu, Wen‐Long Guan, Sheng‐Xiang Rao, Jia‐Fu Ji, Yan Xin, Wei‐Qi Sheng, Hui‐Mian Xu, Zhi‐Wei Zhou, Ai‐Ping Zhou, Jing Jin, Xiang‐Lin Yuan, Feng Bi, Tian‐Shu Liu, Han Liang, Yan‐Qiao Zhang, Guo‐Xin Li, Jun Liang, Bao‐Rui Liu, Lin Shen, Jin Li, Rui‐Hua Xu
Publikováno v:
Cancer Communications, Vol 44, Iss 1, Pp 127-172 (2024)
Abstract The 2023 update of the Chinese Society of Clinical Oncology (CSCO) Clinical Guidelines for Gastric Cancer focuses on standardizing cancer diagnosis and treatment in China, reflecting the latest advancements in evidence‐based medicine, heal
Externí odkaz:
https://doaj.org/article/ddb71d41f751472a92fb64e883303e66
Autor:
Feng‐Hua Wang, Xiao‐Tian Zhang, Yuan‐Fang Li, Lei Tang, Xiu‐Juan Qu, Jie‐Er Ying, Jun Zhang, Ling‐Yu Sun, Rong‐Bo Lin, Hong Qiu, Chang Wang, Miao‐Zhen Qiu, Mu‐Yan Cai, Qi Wu, Hao Liu, Wen‐Long Guan, Ai‐Ping Zhou, Yu‐Jing Zhang, Tian‐Shu Liu, Feng Bi, Xiang‐Lin Yuan, Sheng‐Xiang Rao, Yan Xin, Wei‐Qi Sheng, Hui‐Mian Xu, Guo‐Xin Li, Jia‐Fu Ji, Zhi‐Wei Zhou, Han Liang, Yan‐Qiao Zhang, Jing Jin, Lin Shen, Jin Li, Rui‐Hua Xu
Publikováno v:
Cancer Communications, Vol 41, Iss 8, Pp 747-795 (2021)
Abstract There exist differences in the epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment patterns, and drug selections between gastric cancer patients from the Eastern and Western countries. T
Externí odkaz:
https://doaj.org/article/25078e83af624f808e27aec19309390f
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/ec6296eeaf04498e898b4f0be7b0acdc
Autor:
Dan-Ni Li, Wen-Qing Lu, Bo-Wen Yang, Ling-Yun Zhang, Bo Jin, Shuo Wang, Xiao-Fang Che, Ce Li, Yun-Peng Liu, Xiu-Juan Qu
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundAtezolizumab plus chemotherapy has been recommended as a first-line treatment option for patients with advanced non-small cell lung carcinoma (NSCLC) irrespective of programmed cell death-ligand 1 (PD-L1) expression. Currently, little is kn
Externí odkaz:
https://doaj.org/article/ee0f7283454041c28b3437728e7b3cdf
Autor:
Xing Xin, Ti Wen, Li-Bao Gong, Ming-Ming Deng, Ke-Zuo Hou, Lu Xu, Sha Shi, Xiu-Juan Qu, Yun-Peng Liu, Xiao-Fang Che, Yue-E Teng
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer, which is very difficult to treat and commonly develops resistance to chemotherapy. The following study investigated whether the inhibition of Flap Endonuclease 1 (FEN1) e
Externí odkaz:
https://doaj.org/article/e3771d7ed9c7479bb6a3ed4da61e0638
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Gastric cancer is one of the top five malignant tumors worldwide. At present, the molecular mechanisms of gastric cancer progression are still not completely clear. Cytoplasmic dynein regulates intracellular transport and mitotic spindle localization
Externí odkaz:
https://doaj.org/article/cce9fbe8cc0e47f0822cf163dd578df1
Autor:
Pei-Wen Zhang, Xiu-Juan Qu, Shu-Fang Qian, Xin-Bo Wang, Rui-Di Wang, Qiu-Yue Li, Shi-Yu Liu, Lihong Chen, Dong-Qiang Liu
Publikováno v:
Frontiers in Neuroscience, Vol 12 (2018)
Recent BOLD-fMRI studies have revealed spatial distinction between variability- and mean-based between-condition differences, suggesting that BOLD variability could offer complementary and even orthogonal views of brain function with traditional acti
Externí odkaz:
https://doaj.org/article/e117535f52ff431e8dedffcc1f9e46bf
Publikováno v:
International Journal of Molecular Sciences, Vol 14, Iss 5, Pp 10075-10089 (2013)
Recent studies indicate that β-elemene, a compound isolated from the Chinese herbal medicine Curcuma wenyujin, is capable of reversing tumor MDR, although the mechanism remains elusive. In this study, β-Elemene treatment markedly increased the intr
Externí odkaz:
https://doaj.org/article/265a82a958aa433586e385c07d5295d7
Autor:
Jing-lei Qu, Xiu-juan Qu, Zhi Li, Jing-dong Zhang, Jing Liu, Yue-e Teng, Bo Jin, Ming-fang Zhao, Ping Yu, Jing Shi, Ling-Yu Fu, Zhen-ning Wang, Yun-peng Liu
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0128540 (2015)
Prognostic models are generally used to predict gastric cancer outcomes. However, no model combining patient-, tumor- and host-related factors has been established to predict outcomes after radical gastrectomy, especially outcomes of patients without
Externí odkaz:
https://doaj.org/article/cbc2227c56b44d379cb9c2afffb487d7
Autor:
Jing-lei Qu, Xin Li, Xiu-Juan Qu, Zhi-tu Zhu, Li-zhong Zhou, Yue-e Teng, Jing-dong Zhang, Bo Jin, Ming-fang Zhao, Ping Yu, Yun-peng Liu
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e83196 (2013)
BACKGROUND: Although several clinical trials have suggested that postoperative adjuvant chemotherapy can improve survival of patients with gastric cancer, the optimal treatment duration has not been studied. This retrospective analysis evaluated the
Externí odkaz:
https://doaj.org/article/87c749b87ebf4a249629b896699e7ec1